August another good month for Magellan

Impressive fund performance is continuing to benefit the boutique asset manager.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Established in 2006 Magellan Financial Group (ASX: MFG) has rapidly attracted wholesale and retail investors alike. The group recorded an underlying profit after tax of $48.5 million for the year ended 30 June 2013. That's a rise of 254% on the prior year, largely due to positive international equity markets.

As of 31 August 2013, Magellan had total funds under management (FUM) of approximately $16.4 billion. Just a month earlier, on 31 July, total FUM was less than $16 billion. The increase was a result of total net inflows for the month of $705 million. This included net inflows of $486 million into institutional mandates and $188 million of retail inflows.

Turn the clock back two years and an investor can see quite how outstanding the group's success has been. As of 30 June 2011 total FUM was a mere $2.76 billion, compared to today's $16.4 billion. In that period the group has attracted over $5 billion of institutional investors' money from outside Australia, with much of the success down to operational growth in the United Kingdom and North America.

Unsurprisingly the share price has surged, up over 340% in the past year alone. Several portfolios the group manages have outperformed their benchmarks and that success has fueled the inflows.

The Magellan Group also runs an ASX-listed investment company, the Magellan Flagship Fund (ASX: MFF). It invests in a portfolio of international equities and as the Flagship, has one of Magellan's gun fund managers, Chris Mackay in command.

Foolish takeaway

Ferdinand Magellan the man was a Portuguese explorer and navigator, reputedly the first to circumnavigate the world. The eponymous fund manager is blazing its own global trail and like the sailor, has been enjoying some tailwinds. The modern-day Magellan ship looks to be one still worth getting aboard.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Tom Richardson does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »